固定剂量复方制剂的关键药代动力学要点:案例研究与展望
本文探讨了固定剂量复方制剂在临床应用中需考虑的药代动力学核心问题,指出药物相互作用本身并非复方制剂的负面结局,但相互作用的程度可能需要重新评估两种药物的剂量,并通过多个案例研究提供了开发固定剂量复方制剂的框架和策略。
要点
- 固定剂量复方制剂可提高患者依从性,但需评估药代动力学相互作用。
- 药物相互作用的存在不必然否定复方策略,但程度可能需调整剂量。
- 开发复方制剂应基于关键药代动力学参数进行系统评估。
核心结论
- 固定剂量复方制剂的开发需基于药代动力学 essentials 进行系统评估。
研究设计与样本
- 本文为综述性文章,通过案例研究提供固定剂量复方制剂开发的框架和策略。
主要发现
- 药物相互作用的发生本身并非固定剂量复方制剂的负面结局。
- 药物相互作用的程度可能需要重新评估复方中两种药物的剂量。
临床怎么用
- 临床药师在评估固定剂量复方制剂时,应关注其药代动力学相互作用及剂量合理性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fixed-dose combinations are gaining popularity because they provide convenience while enhancing patient compliance. Literature examples suggest that many fixed-dose combinations are being rationalized and investigated for their potential utility in therapy. This article provides an introspection into the pharmacokinetic essentials that need to be considered prior to implementing a fixed-dose combination strategy. While the drug-drug interaction potential is an important question for the two drugs in a fixed-dose combination, the occurrence of a drug-drug interaction in itself is not a negative outcome for the proposed fixed-dose combination. However, the magnitude of a drug-drug interaction may require a re-assessment of the doses of the two drugs in a fixed-dose combination. Several case studies are provided and discussed to provide a broad perspective on the topic along with a representative framework and strategy on the development of fixed-dose combinations using key pharmacokinetic parameters.
引用
- Dash RP, Rais R, Srinivas NR, et al. Key Pharmacokinetic Essentials of Fixed-Dosed Combination Products: Case Studies and Perspectives. Clin Pharmacokinet. 2018. PMID: 28791593. doi:10.1007/s40262-017-0589-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。